Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053).

Foscarnet and zidovudine (ZDV) pharmacokinetic parameters were not altered in five patients receiving 14 days of concomitant therapy. Foscarnet clearance in plasma averaged (+/- standard deviation) 0.16 +/- 0.03 and 0.13 +/- 0.05 liter/h/kg of body weight in the absence and presence of ZDV. ZDV para...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Aweeka, F T, Gambertoglio, J G, van der Horst, C, Raasch, R, Jacobson, M A
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1992
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192046/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1416864/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.8.1773
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!